Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA

This publication has 50 references indexed in Scilit:

• Stimulation of Human Monocytes with the Gram-Positive Vaccine VectorStreptococcus gordonii
  Clinical and Vaccine Immunology, 2006
• A universal vaccine for serogroup B meningococcus
  Proceedings of the National Academy of Sciences, 2006
• In Vivo Activation of Naive CD4⁺T Cells in Nasal Mucosa-Associated Lymphoid Tissue following Intranasal Immunization with RecombinantStreptococcus gordonii
  Infection and Immunity, 2006
• Prevention and Control of Meningococcal Disease: Recommendations for Use of Meningococcal Vaccines in Pediatric Patients
  Pediatrics, 2005
• Clinical and Microbiological Responses of Volunteers to Combined Intranasal and Oral Inoculation with a Streptococcus gordonii Carrier Strain Intended for Future Use as a Group A Streptococcus Vaccine
  Infection and Immunity, 2005
• NALT- versus PEYER'S-patch-mediated mucosal immunity
  Nature Reviews Immunology, 2004
• Human Dendritic Cells Are Superior to B Cells at Presenting a Major Histocompatibility Complex Class II-Restricted Heterologous Antigen Expressed on RecombinantStreptococcus gordonii
  Infection and Immunity, 2000
• Immunogenicity of the B Monomer ofEscherichia coliHeat-Labile Toxin Expressed on the Surface ofStreptococcus gordonii
  Infection and Immunity, 2000
• A host-vector system for heterologous gene expression in Streptococcus gordonii
  Gene, 1996
• Reactogenicity and Immunogenicity of a Quadrivalent Combined Meningococcal Polysaccharide Vaccine in Children
  The Journal of Infectious Diseases, 1986